Stocks News

LAST PRICE
28.7800
TODAY'S CHANGE (%)
Trending Up0.0400 (0.1392%)

Bid / Lots
27.9100/ 1
Ask / Lots
29.7000/ 1
Open / Previous Close
28.0100 / 28.7400
Day Range
Low 27.9200
High 29.2050
52 Week Range
Low 7.9301
High 47.4500
Volume
1,080,579
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Possible Securities Law Violations, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: DYN
  
  LOS ANGELES, CA / ACCESSWIRE / November 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or "the Company") (NASDAQ:DYN) for violations of the securities laws.
Yesterday
- Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm, from 11:01AM ET on Sunday Nov 03, 2024 by Dow Jones
  11:01AM ET on Sunday Nov 03, 2024 by Dow Jones
  Companies Mentioned: DYN
  
  LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or "the Company") (NASDAQ:DYN) for violations of the securities laws.
Nov 2, 2024
- The Schall Law Firm Encourages Investor Participation In A Case Against Dyne Therapeutics, Inc. For Securities Law Violations, from 11:01AM ET on Saturday Nov 02, 2024 by Dow Jones
  11:01AM ET on Saturday Nov 02, 2024 by Dow Jones
  Companies Mentioned: DYN
  
  LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or "the Company") (NASDAQ:DYN) for violations of the securities laws.
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN, from 11:00AM ET on Saturday Nov 02, 2024 by PR Newswire
  11:00AM ET on Saturday Nov 02, 2024 by PR Newswire
  Companies Mentioned: DYN
  Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980.
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN, from 11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
  11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
  Companies Mentioned: DYN
  
  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
  
  PR Newswire
  
  NEW YORK, Nov. 2, 2024

Today
- Verona Pharma's Q3 Loss Widens, from 13 hours ago by MT Newswires
  13 hours ago by MT Newswires
  Companies Mentioned: VRNA
- Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 14 hours ago by Dow Jones
  14 hours ago by Dow Jones
  Companies Mentioned: VRNA
- Press Release: Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 14 hours ago by Dow Jones
  14 hours ago by Dow Jones
  Companies Mentioned: VRNA
Nov 1, 2024
- DJ 13D Filings -- Barron's, from 9:30PM ET on Friday Nov 01, 2024 by Dow Jones
  9:30PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: BBWI, PARA, PARAA, PBF, JANX, DVAX
- DJ Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors -- Barrons.com, from 6:33PM ET on Friday Nov 01, 2024 by Dow Jones
  6:33PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: BBWI, PARA, PARAA, PBF, JANX, DVAX
Oct 30, 2024
- European Equities Traded in the US as American Depositary Receipts Down Sharply in Wednesday Trading, from 11:08AM ET on Wednesday Oct 30, 2024 by MT Newswires
  11:08AM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: GSK, PHG, VEON, GRFS, VRNA, AUTL, OPRA, GNFT, BCYC, AZN, BCS, CRTO, TCBP, MTLS, CRH, CLLS
Oct 24, 2024
- UBS Initiates Janux Therapeutics With Buy Rating, $69 Price Target, from 11:16AM ET on Thursday Oct 24, 2024 by MT Newswires
  11:16AM ET on Thursday Oct 24, 2024 by MT Newswires
  Companies Mentioned: JANX
- DJ Janux Therapeutics Initiated at Buy by UBS, from 7:46AM ET on Thursday Oct 24, 2024 by Dow Jones
  7:46AM ET on Thursday Oct 24, 2024 by Dow Jones
  Companies Mentioned: JANX
Oct 23, 2024
- Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing, from 3:19AM ET on Wednesday Oct 23, 2024 by MT Newswires
  3:19AM ET on Wednesday Oct 23, 2024 by MT Newswires
  Companies Mentioned: VRNA
- Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing, from 3:17AM ET on Wednesday Oct 23, 2024 by MT Newswires
  3:17AM ET on Wednesday Oct 23, 2024 by MT Newswires
  Companies Mentioned: VRNA

Dyne Therapeutics Inc
NASDAQ:DYNUnited States

Search Criteria

Today

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Possible Securities Law Violations, from 5 hours ago by Dow Jones

Yesterday

Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm, from 11:01AM ET on Sunday Nov 03, 2024 by Dow Jones

Nov 2, 2024

The Schall Law Firm Encourages Investor Participation In A Case Against Dyne Therapeutics, Inc. For Securities Law Violations, from 11:01AM ET on Saturday Nov 02, 2024 by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN, from 11:00AM ET on Saturday Nov 02, 2024 by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN, from 11:00AM ET on Saturday Nov 02, 2024 by Dow Jones

Peers Headlines

Today

Verona Pharma's Q3 Loss Widens, from 13 hours ago by MT Newswires

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 14 hours ago by Dow Jones

Press Release: Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 14 hours ago by Dow Jones

Nov 1, 2024

DJ 13D Filings -- Barron's, from 9:30PM ET on Friday Nov 01, 2024 by Dow Jones

DJ Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors -- Barrons.com, from 6:33PM ET on Friday Nov 01, 2024 by Dow Jones

Oct 30, 2024

European Equities Traded in the US as American Depositary Receipts Down Sharply in Wednesday Trading, from 11:08AM ET on Wednesday Oct 30, 2024 by MT Newswires

Oct 24, 2024

UBS Initiates Janux Therapeutics With Buy Rating, $69 Price Target, from 11:16AM ET on Thursday Oct 24, 2024 by MT Newswires

DJ Janux Therapeutics Initiated at Buy by UBS, from 7:46AM ET on Thursday Oct 24, 2024 by Dow Jones

Oct 23, 2024

Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing, from 3:19AM ET on Wednesday Oct 23, 2024 by MT Newswires

Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing, from 3:17AM ET on Wednesday Oct 23, 2024 by MT Newswires